InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
4
T+90 hit rate
100%
T+90 mean return
+172.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Short Jay M Phd, Chairman & CEO. Director active across 1 company, notably BioAtla, Inc.. Cumulatively, 43 filings have been logged. Split: 4 buys · 4 sells. Total volume traded: €2m. History available since 14 June 2021. The latest transaction was disclosed on 31 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Short Jay M Phd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations43 total
639 shares@ US$0.1680.0% of flowCommon StockSEC:0001193125-26-259702:0
259 shares@ US$3.930.016% mcap0.0% of flowCommon StockSEC:0001193125-26-259702:1
430,000 shares0Common StockSEC:0001193125-26-104134:0
7,728 shares@ US$0.2470.1% of flowCommon StockSEC:0001193125-26-085971:0
6,347 shares@ US$0.9040.2% of flowCommon StockSEC:0001193125-25-304171:0
6,347 shares@ US$0.45550.1% of flowCommon StockSEC:0000950170-25-112618:0
6,347 shares@ US$0.4090.1% of flowCommon StockSEC:0000950170-25-080994:0
431,000 shares0Common StockSEC:0000950170-25-038746:0
30,911 shares@ US$0.460.3% of flowCommon StockSEC:0000950170-25-025969:0
417,000 shares0Common StockSEC:0001209191-24-003507:0
50,000 shares@ US$2.13822.3% of flowCommon StockSEC:0001209191-23-059387:0
Canonical exit: 19 Mar 2024 (T+90)
2,888 shares@ US$1.470.1% of flowCommon StockSEC:0001209191-23-054075:0
2,888 shares@ US$1.700.1% of flowCommon StockSEC:0001209191-23-051187:0
2,888 shares@ US$2.510.2% of flowCommon StockSEC:0001209191-23-048031:0
2,888 shares@ US$2.990.2% of flowCommon StockSEC:0001209191-23-044052:0
2,888 shares@ US$3.000.2% of flowCommon StockSEC:0001209191-23-040669:0
2,888 shares@ US$3.150.2% of flowCommon StockSEC:0001209191-23-033473:0
2,888 shares@ US$3.370.2% of flowCommon StockSEC:0001209191-23-026662:0
2,888 shares@ US$2.680.2% of flowCommon StockSEC:0001209191-23-022431:0
40,800 shares@ US$2.47212.2% of flowCommon StockSEC:0001209191-23-021720:0
Canonical exit: 27 Jun 2023 (T+90)
2,888 shares@ US$2.890.2% of flowCommon StockSEC:0001209191-23-014295:0
3,517 shares@ US$3.790.3% of flowCommon StockSEC:0001209191-23-006438:0
4,667 shares@ US$8.250.9% of flowCommon StockSEC:0001209191-23-000323:0
4,667 shares@ US$11.011.2% of flowCommon StockSEC:0001209191-22-059271:0
3,454 shares@ US$6.890.6% of flowCommon StockSEC:0001209191-22-055169:0
25 of 43 declarations
About Short Jay M Phd
SHORT JAY M PHD is Président-Directeur Général and Chief Executive Officer at BioAtla, Inc. He has filed 43 forms in total; across the sampled recent filings from 2021-06-16 to 2026-06-05, the aggregated amounts show EUR 467572 of buys and EUR 1485364 of sells, with Retenue fiscale as the most common transaction nature.
